ABCB11 deficiency presenting as transient neonatal cholestasis: Correlation with genotypes and BSEP expression

Li‐Ting Li,Zhong‐Die Li,Ye Yang,Yi Lu,Xin‐Bao Xie,Lian Chen,Jia‐Yan Feng,A. S. Knisely,Jian‐She Wang
DOI: https://doi.org/10.1111/liv.14642
IF: 8.754
2020-10-13
Liver International
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background &amp; Aims</h3><p>ABCB11 deficiency presenting in infancy is believed generally to manifest as persistent / progressive cholestasis. We describe a group of patients with biallelic <i>ABCB11</i> variants whose disorder manifested as transient neonatal cholestasis (TNC). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Neonatal intrahepatic cholestasis in 68 children (31 male) with biallelic predictedly pathogenic variants (PPV) in <i>ABCB11</i> was classified as transient (TNC group, n=23, 11 male), intermittent (benign recurrent intrahepatic cholestasis [BRIC] group, n=3, 1 male), or persistent / progressive (progressive familial intrahepatic cholestasis [PFIC] group, n=42, 19 male). Clinical, genetic, and bile salt export pump (BSEP) expression information was correlated with outcomes. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The median onset age of jaundice was 3d (birth to 2m) for the TNC group and 10.5d (birth to 3m) for the PFIC group (<i>P</i> = 0.034). The median length of </p><p>follow‐up of TNC patients was 44mo (12mo‐168mo). At presentation, hepatobiliary‐injury biomarker values were similar between the groups (<i>P</i> &gt;0.05). TNC patients (17/23) more often than PFIC patients (20/42, <i>P</i> = 0.041) harbored biallelic non‐null variants (predicted not to terminate translation prematurely). TNC patient livers (7/7) more often than PFIC patient livers (5/16, <i>P</i> = 0.005) expressed immunohistochemically detectable BSEP. Kaplan‐Meier analysis showed better prognosis for patients with BSEP expression (<i>P</i> = 0.009). Too few BRIC patients were available for statistical study. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Neonatal cholestasis associated with biallelic PPV in <i>ABCB11</i> can resolve temporarily or persistently in one‐third of cases. Resolution is more likely in patients with biallelic non‐null PPV or with liver BSEP expression. </p></section>
gastroenterology & hepatology
What problem does this paper attempt to address?